Washington DC, Spearheading FDA Approval for Maxillofacial Implants

In order to globally treat patients with maxillofacial defects, multiple surgical teams have to be trained. The endorsement of the FDA after PI Branemark and I presented our experience in treating this group of patients, was the first step in achieving global credibility. Our wish is to train and educate our colleagues not only in the surgical techniques, but the development of empathy towards this underserved group of patients.